[go: up one dir, main page]

DE60139389D1 - Vorrichtung und methode zur behandlung von urininkontinenz bei frauen - Google Patents

Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Info

Publication number
DE60139389D1
DE60139389D1 DE60139389T DE60139389T DE60139389D1 DE 60139389 D1 DE60139389 D1 DE 60139389D1 DE 60139389 T DE60139389 T DE 60139389T DE 60139389 T DE60139389 T DE 60139389T DE 60139389 D1 DE60139389 D1 DE 60139389D1
Authority
DE
Germany
Prior art keywords
ring
oxybutynin
urinine
continence
women
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139389T
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Francine Kay
Donald F Koelmel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Womens Health Inc
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60139389D1 publication Critical patent/DE60139389D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DE60139389T 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen Expired - Lifetime DE60139389D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/531,856 US6436428B1 (en) 2000-03-21 2000-03-21 Device and method for treating urinary incontinence in females
PCT/US2001/008978 WO2001070154A1 (en) 2000-03-21 2001-03-21 Device and method for treating urinary incontinence in females

Publications (1)

Publication Number Publication Date
DE60139389D1 true DE60139389D1 (de) 2009-09-10

Family

ID=24119337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139389T Expired - Lifetime DE60139389D1 (de) 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Country Status (12)

Country Link
US (2) US6436428B1 (de)
EP (2) EP2106785B1 (de)
JP (3) JP5265836B2 (de)
AT (1) ATE437630T1 (de)
AU (2) AU4590101A (de)
BR (1) BR0109691A (de)
CA (1) CA2403475C (de)
DE (1) DE60139389D1 (de)
ES (1) ES2332262T3 (de)
IL (2) IL151858A0 (de)
MX (1) MXPA02009358A (de)
WO (1) WO2001070154A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
CN1289064C (zh) * 2001-08-31 2006-12-13 先灵有限责任公司 药物输送体系
AU2002366800B2 (en) * 2001-12-20 2006-08-03 Femmepharma Holding Company, Inc. Vaginal delivery of drugs
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
US6676594B1 (en) 2002-09-18 2004-01-13 Kimberly-Clark Worldwide, Inc. C-shaped vaginal incontinence insert
US6770025B2 (en) 2002-09-18 2004-08-03 Kimberly-Clark Worldwide, Inc. Molar shaped vaginal incontinence insert
US7263999B2 (en) * 2002-10-30 2007-09-04 Kabushiki Kaisha Kitazato Supply Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum
US6808485B2 (en) 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
JP2006515026A (ja) * 2003-01-02 2006-05-18 フェムファーマ ホールディング カンパニー， インコーポレイテッド 乳房の疾患および障害の処置のための薬学的調製物
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US8007568B2 (en) * 2006-04-12 2011-08-30 Millipore Corporation Filter with memory, communication and pressure sensor
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US8177706B2 (en) 2006-07-10 2012-05-15 Mcneil-Ppc, Inc. Method of treating urinary incontinence
CN104257450B (zh) 2006-07-10 2017-05-10 第一次质量卫生公司 弹性装置
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US20080153789A1 (en) * 2006-12-26 2008-06-26 Femmepharma Holding Company, Inc. Topical administration of danazol
EP3470055A1 (de) 2007-06-26 2019-04-17 Allergan Pharmaceuticals International Limited Vorrichtungen zur intravaginalen ausgabe von makromolekülen und wasserlöslichen arzneimitteln
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US20110028922A1 (en) * 2009-07-31 2011-02-03 Kay Dennis M Female External Incontinence Device
AU2011270997A1 (en) * 2010-06-22 2013-01-10 Teva Women's Health, Inc. Intravaginal devices comprising anticholinergic agents, and methods of making thereof
US8980304B2 (en) * 2010-08-20 2015-03-17 Teva Women's Health, Inc. Barrel-shaped vaginal ring
CA2829044A1 (en) * 2011-03-03 2012-09-07 Allergan, Inc. Silicone-based ophthalmic formulations
JP2018509389A (ja) * 2015-01-30 2018-04-05 リ・ガリ・ベスローテン・フエンノートシャップＬｉ Ｇａｌｌｉ Ｂ．Ｖ． 膣用薬物送達デバイス
EP4628016A3 (de) 2017-10-27 2025-12-17 Axena Health, Inc. Vorrichtungen, systeme und verfahren zum trainieren der beckenbodenmuskeln
CN119952301A (zh) * 2025-04-10 2025-05-09 中国核动力研究设计院 一种远距离激光切割头及其调焦方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4402695A (en) 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
ES2137261T3 (es) 1992-05-13 1999-12-16 Alza Corp Administracion transdermica de oxibutinina.
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
EP0743842B1 (de) 1994-03-07 2003-08-13 Theratech, Inc. Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5532278A (en) 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5674895A (en) * 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
KR20010029519A (ko) 1996-09-19 2001-04-06 이곤 이 버그 요실금 치료 방법
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
US6087396A (en) 1998-10-05 2000-07-11 Situs Corporation Oxybutynin formulations and method of use
WO2000019997A1 (en) 1998-10-07 2000-04-13 Alza Corporation Controlled release dosage from comprising oxybutynin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
DE602005026290D1 (de) * 2004-07-09 2011-03-24 Population Council Inc Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren

Also Published As

Publication number Publication date
CA2403475C (en) 2011-02-08
EP2106785B1 (de) 2016-12-07
EP2106785A1 (de) 2009-10-07
IL151858A (en) 2009-12-24
MXPA02009358A (es) 2003-09-25
HK1053254A1 (en) 2003-10-17
WO2001070154A1 (en) 2001-09-27
WO2001070154A9 (en) 2001-12-20
JP5675865B2 (ja) 2015-02-25
ES2332262T3 (es) 2010-02-01
JP2013107895A (ja) 2013-06-06
US20020090390A1 (en) 2002-07-11
ATE437630T1 (de) 2009-08-15
EP1278494A4 (de) 2005-11-02
CA2403475A1 (en) 2001-09-27
AU2001245901B2 (en) 2004-10-07
JP2014210802A (ja) 2014-11-13
EP1278494B1 (de) 2009-07-29
IL151858A0 (en) 2003-04-10
EP1278494A1 (de) 2003-01-29
US6436428B1 (en) 2002-08-20
BR0109691A (pt) 2003-06-10
JP5265836B2 (ja) 2013-08-14
AU4590101A (en) 2001-10-03
JP5986149B2 (ja) 2016-09-06
JP2003527404A (ja) 2003-09-16

Similar Documents

Publication Publication Date Title
DE60139389D1 (de) Vorrichtung und methode zur behandlung von urininkontinenz bei frauen
NO20065380L (no) Anvendelse av R-(+)-2-(3-diisopropylamino-l-fenylpropyl)-4-hydroksymetyl-fenylisosmorsyrehydrogenfumarat for fremstilling av et medikament for behandling av urininkontinens og andre spasmogeniske sykdommer.
DE60141145D1 (de)
CY1108296T1 (el) Σετ χειρουργικων εργαλειων για τη θεραπεια της γυναικειας ακρατειας ουρων
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DE60220858D1 (de) Intravaginalvorrichtung zur Verhinderung von weiblicher Harninkontinenz
JP2003527404A5 (de)
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
MX9605419A (es) Formas de dosificacion de liberacion controlada de azitromicina.
MXPA05009816A (es) Composiciones y metodos para el tratamiento de la eyaculacion precoz.
NZ509894A (en) A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
MXPA04003977A (es) Baja concentracion de peroxido para tratamiento o prevencion de infecciones vaginales.
BR0014146A (pt) Aparelho e método para anestesiar a região cervical de uma fêmea
AU1898597A (en) Novel intrauterine device for use as contraceptive means in female dogs and methods of insertion thereof
EP1506001A4 (de) Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
ATE415953T1 (de) Vorrichtung zur wirkstofffreisetzung mit einer netzhülse
MY122216A (en) New vaccine and method of use
BRPI0408126B8 (pt) implante para lábios
DE69834568D1 (de) Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal
GB9227123D0 (en) Method
DE60206888D1 (de) Harninkontinenzvorrichtung
HUP0002151A2 (hu) Transzuretrális eszköz
Toeplitz et al. RHINOSCLEROMA.
Chen Refinement of McIndoe's vaginal reconstruction with ORFIT “S” vaginal stent
BG101173A (en) Vaccine against pasteurellosis and haemorrhagic disease in rabbits

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1278494

Country of ref document: EP

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LUXEMBOURG, LU